Uric acid is independently associated with diabetic kidney disease: A cross-sectional study in a Chinese population

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Yan, Dandan ^a   Tu, Yinfang ^a   Jiang, Feng ^a   Wang, Jie ^a   Zhang, Rong ^a   Sun, Xue ^a   Wang, Tao ^a   Wang, Shiyun ^a   Bao, Yuqian ^a   Hu, Cheng ^a,b   Jia, Weiping ^a  

^a Shanghai Key Laboratory of Diabeties Mellitus Shanghai Diabetes Institute Shanghai Clinical Center for Diabetes   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; URIC ACID BLOOD LEVEL; BLOOD; CHINA; COMPLICATION; DIABETIC NEPHROPATHIES; MIDDLE AGED; PREVALENCE; RISK FACTOR;

BIOMARKERS; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; URIC ACID;

EID: 84934951895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129797     Document Type: Article

References (35)

1. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 2000; 148(1):131-9. Epub 1999/12/02. doi: S0021-9150(99)00214-2 [pii]. PMID: 10580179.
2. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008; 27(6):608-19. Epub 2008/07/05. doi: 10.1080/15257770802138558 PMID: 18600514; PubMed Central PMCID: PMCPmc2895915.
3. Sheikhbahaei S, Fotouhi A, Hafezi-Nejad N, Nakhjavani M, Esteghamati A. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes. Metab Syndr Relat Disord. 2014; 12(2):102-9. Epub 2014/01/23. doi: 10.1089/met.2013.0119 PMID: 24447037.
4. Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine. 2011; 40(1):109-16. doi: 10.1007/s12020-011-9449-2 PMID: 21431449.
5. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003; 41(6):1183-90. Epub 2003/04/23. doi: 10.1161/01.hyp.0000069700.62727.c5 PMID: 12707287.
6. Feig DI, Mazzali M, Kang DH, Nakagawa T, Price K, Kannelis J, et al. Serum uric acid: a risk factor and a target for treatment? J Am Soc Nephrol. 2006; 17(4 Suppl 2):S69-73. Epub 2006/03/28. doi: 10.1681/asn.2005121331 PMID: 16565251.
7. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002; 13(12):2888-97. Epub 2002/11/22. PMID: 12444207.
8. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009; 169(4):342-50. Epub 2009/02/25. doi: 169/4/342 [pii] doi: 10.1001/archinternmed.2008.605 PMID: 19237717; PubMed Central PMCID: PMC2727643.
9. Lim A. Diabetic nephropathy-complications and treatment. Int J Nephrol Renovasc Dis. 2014; 7:361-81. Epub 2014/10/25. doi: 10.2147/IJNRD.S40172 ijnrd-7-361 [pii]. PMID: 25342915; PubMed Central PMCID: PMC4206379.
10. Altemtam N, Russell J, El Nahas M. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant. 2012; 27(5):1847-54. doi: 10.1093/ndt/gfr561 PMID: 22058177.
11. Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res. 2013; 36(1):43-9. Epub 2012/09/07. doi: 10.1038/hr.2012.135 PMID: 22951520.
12. Shichiri M, Iwamoto H, Marumo F. Diabetic hypouricemia as an indicator of clinical nephropathy. Am J Nephrol. 1990; 10(2):115-22. Epub 1990/01/01. PMID: 2190467.
13. Beck L. Requiem for gouty nephropathy. Kidney Int. 1986; 30(2):280-7. PMID: 3761864
14. Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014; 26(2):186-91. Epub 2014/01/15. doi: 10.1097/BOR.0000000000000028 PMID: 24419750.
15. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006; 17(10):2937-44. Epub 2006/09/22. doi: ASN.2006040368 [pii] doi: 10.1681/ASN.2006040368 PMID: 16988059.
16. Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014; 63(2 Suppl 2):S39-62. Epub 2014/01/28. doi: S0272-6386(13)01431-5 [pii] doi: 10.1053/j.ajkd.2013.10.048 PMID: 24461729.
17. Johnson RJ, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant. 2013; 28(9):2221-8. Epub 2013/04/02. doi: 10.1093/ndt/gft029 PMID: 23543594.
18. Miyaoka T, Mochizuki T, Takei T, Tsuchiya K, Nitta K. Serum uric acid levels and long-term outcomes in chronic kidney disease. Heart Vessels. 2014; 29(4):504-12. Epub 2013/08/10. doi: 10.1007/s00380-013-0396-0 PMID: 23929090.
19. Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012; 35(1):99-104. Epub 2011/10/27. doi: 10.2337/dc11-1346 PMID: 22028277; PubMed Central PMCID: PMCPmc3241303.
20. Jalal DI, Maahs DM, Hovind P, Nakagawa T. Uric acid as a mediator of diabetic nephropathy. Semin Nephrol. 2011; 31(5):459-65. doi: 10.1016/j.semnephrol.2011.08.011 PMID: 22000654; PubMed Central PMCID: PMC3197214.
21. Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, et al. Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus. PLoS One. 2011; 6(11):e27817. doi: 10.1371/journal.pone.0027817 PMID: 22125626; PubMed Central PMCID: PMC3220675.
22. Cai XL, Han XY, Ji LN. High-normal serum uric acid is associated with albuminuria and impaired glomerular filtration rate in Chinese type 2 diabetic patients. Chin Med J (Engl). 2011; 124(22):3629-34. Epub 2012/02/22. PMID: 22340215.
23. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol. 2005; 70(3):343-54. Epub 2005/06/21. doi: S0006-2952(05)00322-9 [pii] doi: 10.1016/j.bcp.2005.05.009 PMID: 15963955.
24. Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids. 2008; 27(8):967-78. Epub 2008/08/13. doi: 901524893 [pii] doi: 10.1080/15257770802257952 PMID: 18696365; PubMed Central PMCID: PMC2701227.
25. Nakagawa T, Tanabe K, Croker BP, Johnson RJ, Grant MB, Kosugi T, et al. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat Rev Nephrol. 2011; 7(1):36-44. Epub 2010/11/04. doi: nrneph.2010.152 [pii] doi: 10.1038/nrneph.2010.152 PMID: 21045790; PubMed Central PMCID: PMC3653134.
26. Filiopoulos V, Hadjiyannakos D, Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail. 2012; 34(4):510-20. Epub 2012/01/21. doi: 10.3109/0886022X.2011.653753 PMID: 22260409.
27. Singh DK, Winocour P, Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol. 2011; 7(3):176-84. Epub 2010/12/15. doi: nrendo.2010.212 [pii] doi: 10.1038/nrendo.2010.212 PMID: 21151200.
28. Arora MK, Singh UK. Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy. Curr Drug Targets. 2014; 15(5):531-8. Epub 2014/03/25. doi: CDT-EPUB-59730 [pii]. PMID: 24655140.
29. Kao MP, Ang DS, Gandy SJ, Nadir MA, Houston JG, Lang CC, et al. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 2011; 22(7):1382-9. Epub 2011/07/02. doi: ASN.2010111185 [pii] doi: 10.1681/ASN.2010111185 PMID: 21719783; PubMed Central PMCID: PMC3137586.
30. Kanbay M, Huddam B, Azak A, Solak Y, Kadioglu GK, Kirbas I, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011; 6(8):1887-94. Epub 2011/07/26. doi: CJN.11451210 [pii] doi: 10.2215/CJN.11451210 PMID: 21784838; PubMed Central PMCID: PMC3359530.
31. Choi HK, Ford ES. Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels-the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford). 2008; 47(5):713-7. Epub 2008/04/09. doi: ken066 [pii] doi: 10.1093/rheumatology/ken066 PMID: 18390895.
32. Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl. 2011;(120:):S1-6. Epub 2011/03/05. doi: ki2010509 [pii] doi: 10.1038/ki.2010.509 PMID: 21358696.
33. Sakurai H. Urate transporters in the genomic era. Curr Opin Nephrol Hypertens. 2013; 22(5):545-50. Epub 2013/07/16. doi: 10.1097/MNH.0b013e328363ffc8 PMID: 23852331.
34. Chino Y, Samukawa Y, Sakai S, Nakai Y, Yamaguchi J, Nakanishi T, et al. SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria. Biopharm Drug Dispos. 2014; 35(7):391-404. Epub 2014/07/22. doi: 10.1002/bdd.1909 PMID: 25044127; PubMed Central PMCID: PMC4223977.
35. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, Doblado M, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med. 2008; 5(10):e197. Epub 2008/10/10. doi: 08-PLME-RA-0340 [pii] doi: 10.1371/journal.pmed.0050197 PMID: 18842065; PubMed Central PMCID: PMC2561076.